INTERNATIONAL THYROID ONCOLOGY GROUP (ITOG) (EIN 204773370) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2006

Legal Domicile

Principal Officer

DWIGHT VICKS III

Phone

3152722455

Tax Period

2024-01-01 to 2024-12-31

INTERNATIONAL THYROID ONCOLOGY GROUP (ITOG), founded in 2006, is a small nonprofit in the Medical Research sector that reported $542K in total revenue in fiscal year 2024. Revenue surged 43% from the prior year, signaling strong growth momentum. The organization ran a surplus of $181K, a strong 33% operating margin.

Mission

THE INTERNATIONAL THYROID ONCOLOGY GROUP HAS BEEN ORGANIZED AND WILL BE OPERATED EXCLUSIVELY TO SERVE THE EXEMPT PURPOSE OF (1) FURTHERING SCIENTIFIC RESEARCH INTO POSSIBLE CURES FOR THYROID CANCER; AND (2) EDUCATING THE PUBLIC REGARDING THYROID CANCER AND RESEARCH INTO POSSIBLE CURES FOR THE DISEASE BY HOSTING CONFERENCES, MEETINGS, AND OTHER EDUCATIONAL PROGRAMS, AND BY DISSEMINATING RESEARCH RESULTS REGARDING THYROID CANCER TREATMENTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $283,190

Program Service Revenue $0

Investment Income $258,614

Other Revenue $0

TOTAL REVENUE $541,804

Expense Breakdown

Grants Paid $56,154

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $226,154

Other Expenses $304,954

TOTAL EXPENSES $361,108

Year-over-Year Comparison

	2024	2023	Change
Revenue	$541,804	$379,506	+0.4%
Expenses	$361,108	$211,213	+0.7%
Net Income	$180,696	$168,293	+0.1%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

100

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DWIGHT VICKS III MBA	CFO/ CO-FOUNDER	5.00	Officer Director	$0	$0	$0
LAURA FUGAZZOLA	DIRECTOR	2.00	Director	$0	$0	$0
CARMELLO NUCERA	DIRECTOR	5.00	Director	$0	$0	$0
NAIFA BUSAIDY MD	DIRECTOR	2.00	Director	$0	$0	$0
JULIE ANN SOSA MD	FINANCE CHAIR	2.00	Director	$0	$0	$0
ALAN HO MD PHD	CORRELATIVE CHAIR	2.00	Director	$0	$0	$0
GREGORY RANDOLPH MD	PRESIDENT	2.00	Officer Director	$0	$0	$0
CHRISTINE SPITZWEG	DIRECTOR	2.00	Director	$0	$0	$0
LAURA BOUCAI MD	SECRETARY	2.00	Officer Director	$0	$0	$0
FRANK WORDEN MD	PROTOCOL COMMITTE CHAIR	2.00	Director	$0	$0	$0
IAN GANLEY MD PHD	DIRECTOR	2.00	Director	$0	$0	$0
LINDSEY BISCHOFF MD	DIRECTOR	2.00	Director	$0	$0	$0
SARIMAR AGOSTO SALGADO MD	DIRECTOR	2.00	Director	$0	$0	$0
VICTOR MERNET MD	DIRECTOR	2.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$541,804	$361,108	$4,343,548	$180,696
2023	$379,506	$211,213	$4,087,622	$168,293
2022	$420,403	$167,566	$3,731,345	$252,837
2021	$370,669	$126,509	$3,897,331	$244,160
2020	$335,388	$96,740	$3,534,997	$238,648
2019	$413,941	$159,882	$3,126,284	$254,059
2018	$710,419	$227,647	$2,723,793	$482,772

INTERNATIONAL THYROID ONCOLOGY GROUP (ITOG)